Cargando…

Unpacking commercial sector opposition to European smoke-free policy: lack of unity, ‘fear of association’ and harm reduction debates

OBJECTIVE: Tobacco companies have made extensive efforts to build alliances against comprehensive smoke-free legislation. This article analyses the interaction between actors who opposed the development of the European Council Recommendation on smoke-free environments. METHODS: Drawing on data from...

Descripción completa

Detalles Bibliográficos
Autores principales: Weishaar, Heide, Amos, Amanda, Collin, Jeff
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606975/
https://www.ncbi.nlm.nih.gov/pubmed/26055268
http://dx.doi.org/10.1136/tobaccocontrol-2014-052007
_version_ 1782395448470798336
author Weishaar, Heide
Amos, Amanda
Collin, Jeff
author_facet Weishaar, Heide
Amos, Amanda
Collin, Jeff
author_sort Weishaar, Heide
collection PubMed
description OBJECTIVE: Tobacco companies have made extensive efforts to build alliances against comprehensive smoke-free legislation. This article analyses the interaction between actors who opposed the development of the European Council Recommendation on smoke-free environments. METHODS: Drawing on data from 200 policy documents and 32 semistructured interviews and using qualitative textual analysis and organisational network analysis, opponents’ positions on, and responses to, the policy initiative, strategies to oppose the policy, and efforts to build alliances were investigated. RESULTS: The non-binding nature of the policy, scientific evidence and clear political will to adopt EU-wide measures combined to limit the intensity of commercial sector opposition to the comprehensive EU smoke-free policy. Most tobacco companies, led by the Confederation of European Community Cigarette Manufacturers (CECCM), voiced reservations against the proposal, criticised the policy process and fought flanking measures on product regulation. However, some companies focused on instigating harm reduction debates. These divergent approaches and the reluctance of other commercial actors to demonstrate solidarity with the tobacco sector prevented the establishment of a cohesive commercial sector alliance. CONCLUSIONS: The comparatively limited opposition to EU smoke-free policy contrasts with previous accounts of tobacco industry resistance to tobacco control. While context-specific factors can partially explain these differences, the paper indicates that the sector's diminished credibility and lack of unity hampered political engagement and alliance building. Industry efforts to emphasise the benefits of smokeless tobacco during smoke-free policy debates highlight the potential of harm reduction as a gateway for tobacco companies to re-enter the political arena.
format Online
Article
Text
id pubmed-4606975
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-46069752016-07-01 Unpacking commercial sector opposition to European smoke-free policy: lack of unity, ‘fear of association’ and harm reduction debates Weishaar, Heide Amos, Amanda Collin, Jeff Tob Control Research Paper OBJECTIVE: Tobacco companies have made extensive efforts to build alliances against comprehensive smoke-free legislation. This article analyses the interaction between actors who opposed the development of the European Council Recommendation on smoke-free environments. METHODS: Drawing on data from 200 policy documents and 32 semistructured interviews and using qualitative textual analysis and organisational network analysis, opponents’ positions on, and responses to, the policy initiative, strategies to oppose the policy, and efforts to build alliances were investigated. RESULTS: The non-binding nature of the policy, scientific evidence and clear political will to adopt EU-wide measures combined to limit the intensity of commercial sector opposition to the comprehensive EU smoke-free policy. Most tobacco companies, led by the Confederation of European Community Cigarette Manufacturers (CECCM), voiced reservations against the proposal, criticised the policy process and fought flanking measures on product regulation. However, some companies focused on instigating harm reduction debates. These divergent approaches and the reluctance of other commercial actors to demonstrate solidarity with the tobacco sector prevented the establishment of a cohesive commercial sector alliance. CONCLUSIONS: The comparatively limited opposition to EU smoke-free policy contrasts with previous accounts of tobacco industry resistance to tobacco control. While context-specific factors can partially explain these differences, the paper indicates that the sector's diminished credibility and lack of unity hampered political engagement and alliance building. Industry efforts to emphasise the benefits of smokeless tobacco during smoke-free policy debates highlight the potential of harm reduction as a gateway for tobacco companies to re-enter the political arena. BMJ Publishing Group 2016-07 2015-06-08 /pmc/articles/PMC4606975/ /pubmed/26055268 http://dx.doi.org/10.1136/tobaccocontrol-2014-052007 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
spellingShingle Research Paper
Weishaar, Heide
Amos, Amanda
Collin, Jeff
Unpacking commercial sector opposition to European smoke-free policy: lack of unity, ‘fear of association’ and harm reduction debates
title Unpacking commercial sector opposition to European smoke-free policy: lack of unity, ‘fear of association’ and harm reduction debates
title_full Unpacking commercial sector opposition to European smoke-free policy: lack of unity, ‘fear of association’ and harm reduction debates
title_fullStr Unpacking commercial sector opposition to European smoke-free policy: lack of unity, ‘fear of association’ and harm reduction debates
title_full_unstemmed Unpacking commercial sector opposition to European smoke-free policy: lack of unity, ‘fear of association’ and harm reduction debates
title_short Unpacking commercial sector opposition to European smoke-free policy: lack of unity, ‘fear of association’ and harm reduction debates
title_sort unpacking commercial sector opposition to european smoke-free policy: lack of unity, ‘fear of association’ and harm reduction debates
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606975/
https://www.ncbi.nlm.nih.gov/pubmed/26055268
http://dx.doi.org/10.1136/tobaccocontrol-2014-052007
work_keys_str_mv AT weishaarheide unpackingcommercialsectoroppositiontoeuropeansmokefreepolicylackofunityfearofassociationandharmreductiondebates
AT amosamanda unpackingcommercialsectoroppositiontoeuropeansmokefreepolicylackofunityfearofassociationandharmreductiondebates
AT collinjeff unpackingcommercialsectoroppositiontoeuropeansmokefreepolicylackofunityfearofassociationandharmreductiondebates